Ensign Peak Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.02M | Hold |
|
|||||
|
2023
Q3 | $559K | Hold |
|
|||||
|
2023
Q2 | $924K | Hold |
|
|||||
|
2023
Q1 | $1.19M | Hold |
|
|||||
|
2022
Q4 | $1M | Sell |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $914K | Sell |
|
|||||
|
2022
Q1 | $2.51M | Hold |
|
|||||
|
2021
Q4 | $3.76M | Buy |
|
|||||
|
2021
Q3 | $1.92M | Sell |
|
|||||
|
2021
Q2 | $3.04M | Hold |
|
|||||
|
2021
Q1 | $2.44M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Hold |
|
|||||
|
2020
Q3 | $646K | Buy |
|